Open this photo in gallery: Paxlovid is the most commonly prescribed at home treatment for COVID-19 in the U.S.Wolfgang Rattay/Reuters A 15-day course of Pfizer’s COVID-19...
By Michael Erman (Reuters) – A 15-day course of Pfizer’s COVID-19 antiviral treatment Paxlovid did not relieve symptoms of long COVID, according a study by Stanford...
British Columbia will cover the cost of an antiviral drug aimed at treating mild to moderate cases of COVID-19 as the federal government ends its coverage....